Observational studyPacing and clinical electrophysiology : PACE2026
Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes.
Observational study in Pacing and clinical electrophysiology : PACE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulsed Field Ablation for Atrial Fibrillation in Obesity: Reassessing Risk, Safety, and Success.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProcedural and clinical outcomes in patients with obesity undergoing catheter ablation for atrial fibrillation (AF) have been mixed. Clinical data in the context of pulsed field ablation (PFA) are currently limited in this patient cohort.
methodsWe conducted an observational study of consecutive patients undergoing PFA with a pentaspline catheter (Farapulse
results537 (95%) out of 564 consecutive patients underwent de novo PFA for AF between 2022 and 2025 with a recorded BMI; 326 (60.7%) were nonobese, 117 (21.8%) were obese and 94 (17.5%) morbidly obese patients. Proportion of females increased according to BMI (p = 0.003). Obesity correlated with CHA
conclusionPatients with obesity had no signal of increased risk detected with regard to procedural safety and clinical outcomes with PFA for AF compared with nonobese patients. These findings apply to a specific pentaspline PFA catheter rather than PFA technology in general.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.